Registry For Patients Treated With BeneFix In Usual Care Setting In Germany

• Status: Completed
• Trial end date: 2016-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this observational study is to describe the incidence of adverse events among patients treated with BeneFix® in usual health care settings in Germany.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer

Criteria

Inclusion Criteria:

• Patients with hemophilia B already receiving or starting treatment with reformulated BeneFIX®.

Exclusion Criteria:

• Patients with hemophilia B treated with a product other than BeneFIX®.

• Inclusion in the ongoing prospective registry of European hemophilia B patients using BeneFIX®.